announcement coming, page-32

Adorites....

"Several European companies with whom we have been in dialogue for some time have
finally identified what they believe to be opportunities that would benefit greatly from the use
of Mix&Go, both in the short and long term. Dr Joe Maeji and I will meet relevant people to
assess their needs and the likelihood that we can be of commercial benefit. The audience
includes scientific, clinical and commercial staff from research, pharma and diagnostic areas
of their respective businesses. We are excited by the prospects and look forward to
investigating the variety of applications requested"

Roche?????